BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 25230354)

  • 1. Post-approval studies in France, challenges facing medical devices.
    Levesque K; Coqueblin C; Guillot B; ; Aubourg L; Avouac B; Carbonneil C; Cucherat M; Descamps-Mandine P; Hanoka S; Goldberg M; Josseran A; Parquin F; Pitel S; Ratignier C; Sechoy O; Szwarcenstein K; Tanti A; Teiger E; Thevenet N
    Therapie; 2014; 69(4):303-21. PubMed ID: 25230354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scientific evaluation and pricing of medical devices and associated procedures in France.
    Gilard M; Debroucker F; Dubray C; ; Allioux Y; Aper E; Barat-Leonhardt V; Brami M; Carbonneil C; Chartier-Kastler E; Coqueblin C; Fare S; Giri I; Goehrs JM; Levesque K; Maugendre P; Parquin F; Sales JP; Szwarcensztein K
    Therapie; 2013; 68(4):193-208. PubMed ID: 23981256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safe Medical Devices Act: management guidance for hospital compliance with the new FDA requirements.
    Alder HC
    Hosp Technol Ser; 1993 Oct; 12(11):1-27. PubMed ID: 10129209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011.
    Rathi VK; Krumholz HM; Masoudi FA; Ross JS
    JAMA; 2015 Aug; 314(6):604-12. PubMed ID: 26262798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The limited state of technology assessment for medical devices: facing the issues.
    Ramsey SD; Luce BR; Deyo R; Franklin G
    Am J Manag Care; 1998 Sep; 4 Spec No():SP188-99. PubMed ID: 10185994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [French Health Authority (HAS) Guidance: the post-registration studies on health technologies (drugs, medical devices and instruments): principles and methods].
    Stamenkovic S; Solesse A; Zanetti L; Zagury P; Vray M;
    Therapie; 2012; 67(5):409-21. PubMed ID: 23241250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical devices on trial, Part I.
    Wright D
    Med Device Technol; 2002 Dec; 13(10):35-8. PubMed ID: 12575529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and implementation of a portal for the medical equipment market: MEDICOM.
    Palamas S; Kalivas D; Panou-Diamandi O; Zeelenberg C; van Nimwegen C
    J Med Internet Res; 2001; 3(4):E32. PubMed ID: 11772547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Introduction of innovative high-risk medical devices in Europe: are clinical efficacy and safety guaranteed?].
    Stordeur S; Vinck I; Neyt M; Van Brabandt H; Hulstaert F
    Rev Epidemiol Sante Publique; 2013 Apr; 61(2):105-10. PubMed ID: 23477881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Italian device registration requirements.
    Donawa M
    Med Device Technol; 2008; 19(3):26, 28-9, 31. PubMed ID: 18557406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FACTORS INFLUENCING REIMBURSEMENT OF MEDICAL DEVICES IN FRANCE.
    Loge P; Delalande F; Reymond MC; Germain S
    Int J Technol Assess Health Care; 2015; 31(6):399-406. PubMed ID: 26868190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of the medical device directives in Italy.
    Donawa ME
    Med Device Technol; 2002 Jun; 13(5):26-8. PubMed ID: 12116733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current challenges for clinical trials of cardiovascular medical devices.
    Zannad F; Stough WG; PiƱa IL; Mehran R; Abraham WT; Anker SD; De Ferrari GM; Farb A; Geller NL; Kieval RS; Linde C; Redberg RF; Stein K; Vincent A; Woehrle H; Pocock SJ
    Int J Cardiol; 2014 Jul; 175(1):30-7. PubMed ID: 24861254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to improve the clinical development paradigm and its division into phases I, II and III.
    Bamberger M; Moore N; Lechat P;
    Therapie; 2011; 66(4):331-4, 327-30. PubMed ID: 21851796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceuticals and medical devices: medical devices.
    Berry MD
    Issue Brief Health Policy Track Serv; 2013 Dec; ():1-49. PubMed ID: 24482892
    [No Abstract]   [Full Text] [Related]  

  • 16. [Medical devices vigilance].
    Crickx B
    Ann Dermatol Venereol; 2008 Jan; 135(1 Pt 2):1S70-2. PubMed ID: 18442667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The control of medical devices in Canada. Canadian Society of Laboratory Technologists.
    Can J Med Technol; 1991; 53(4):198-200. PubMed ID: 10119488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gastroenterologist and industry: changing winds.
    Delegge MH
    Gastrointest Endosc Clin N Am; 2012 Jan; 22(1):121-34. PubMed ID: 22099718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hospital-based health technology assessment in France: how to proceed to evaluate innovative medical devices?].
    Martelli N; van den Brink H; Denies F; Dervaux B; Germe AF; Prognon P; Pineau J
    Ann Pharm Fr; 2014 Jan; 72(1):3-14. PubMed ID: 24438663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The changing environment for technological innovation in health care.
    Goodman CS; Gelijns AC
    Baxter Health Policy Rev; 1996; 2():267-315. PubMed ID: 11066263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.